04-09-2020, 09:04 PM
A fast-tracked therapy shows promisehttps://hub.jhu.edu/2020/04/08/arturo-ca...a-profile/
Under the leadership of immunologist Arturo Casadevall, Johns Hopkins has spearheaded an effort to use convalescent serum therapy as a potential COVID-19 treatment, helping to establish a network of at least 40 hospitals and blood banks in 20 states to collect, isolate, and process blood plasma from COVID-19 survivors. If early promising studies on the therapy done in China are confirmed by U.S. trials, thousands of survivors might soon line up to donate their antibody-rich plasma. "I absolutely think this could be the best treatment we have for the next few months," Hopkins pathologist Aaron Tobian says.